Cargando…

Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification

Accumulating evidence suggests that renal cell tumors represent a group of histologically and molecularly heterogeneous diseases, even within the same histological subtype. In accordance with the increased understanding of the morphological, immunohistochemical, molecular, and epidemiological charac...

Descripción completa

Detalles Bibliográficos
Autor principal:	Inamura, Kentaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666876/ https://www.ncbi.nlm.nih.gov/pubmed/29053609 http://dx.doi.org/10.3390/ijms18102195

Ejemplares similares

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
por: Inamura, Kentaro
Publicado: (2018)

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
por: Inamura, Kentaro
Publicado: (2017)

Colorectal Cancers: An Update on Their Molecular Pathology
por: Inamura, Kentaro
Publicado: (2018)

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features
por: Inamura, Kentaro
Publicado: (2017)

Bladder Cancer: New Insights into Its Molecular Pathology
por: Inamura, Kentaro
Publicado: (2018)

Aggressive lymphoma 2016: revision of the WHO classification
por: Beham-Schmid, Christine
Publicado: (2017)

Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification
por: Yu, Juan, et al.
Publicado: (2020)

Epidemiology of de novo Acute Myeloid Leukemia in Kuwait per the 2016 WHO Classification
por: Alshemmari, Salem H., et al.
Publicado: (2022)

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors?
por: Surintrspanont, Jerasit, et al.
Publicado: (2023)

Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
por: Inamura, Kentaro
Publicado: (2017)

Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression
por: Inamura, Kentaro
Publicado: (2018)

NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification
por: Shirota, Masami, et al.
Publicado: (2021)

WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies
por: Warren, Anne Y., et al.
Publicado: (2018)

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma
por: Inamura, Kentaro, et al.
Publicado: (2019)

Neoplasms and tumor-like lesions of the sellar region: imaging findings with correlation to pathology and 2021 WHO classification
por: Ugga, Lorenzo, et al.
Publicado: (2023)

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
por: KOMORI, Takashi
Publicado: (2017)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Molecular pathological classification of colorectal cancer
por: Müller, Mike F., et al.
Publicado: (2016)

News in the classification of WHO 2022 bladder tumors
por: Raspollini, Maria Rosaria, et al.
Publicado: (2023)

Beyond Bacteria: Fungi in the Tumor Microbiome
por: Inamura, Kentaro
Publicado: (2023)

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
por: Barbui, Tiziano, et al.
Publicado: (2018)

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
por: Pfister, Stefan M., et al.
Publicado: (2022)

Mixed odontogenic tumors: A review of the clinicopathological and molecular features and changes in the WHO classification
por: Sánchez-Romero, Celeste, et al.
Publicado: (2021)

Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification
por: Jung, Jin, et al.
Publicado: (2019)

Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification
por: Kriachok, Iryna, et al.
Publicado: (2022)

Pathological Classification of Focal Cortical Dysplasia (FCD) : Personal Comments for Well Understanding FCD Classification
por: Kim, Se Hoon, et al.
Publicado: (2019)

Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma
por: Shapiro, Daniel D., et al.
Publicado: (2023)

Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary Adenocarcinoma
por: Ninomiya, Hironori, et al.
Publicado: (2022)

Cerebral Thromboembolism after Lobectomy for Lung Cancer: Pathological Diagnosis and Mechanism of Thrombus Formation
por: Hashimoto, Hirotsugu, et al.
Publicado: (2019)

Understanding the molecular epidemiology of foot-and-mouth-disease virus
por: Klein, Joern
Publicado: (2009)

A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
por: Roufosse, Candice, et al.
Publicado: (2018)

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas
por: Paul, Yashna, et al.
Publicado: (2017)

Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
por: Inamura, Kentaro
Publicado: (2017)

Update on Immunohistochemistry for the Diagnosis of Lung Cancer
por: Inamura, Kentaro
Publicado: (2018)

Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance
por: Walther, Zenta, et al.
Publicado: (2011)

Pathological Bases for a Robust Application of Cancer Molecular Classification
por: Diaz-Cano, Salvador J.
Publicado: (2015)

Tumor-resident intracellular bacteria benefit metastasis
por: Koyama, Kei, et al.
Publicado: (2023)

Current Trends in the Molecular Classification of Renal Neoplasms
por: Young, Andrew N., et al.
Publicado: (2006)

Malignant Catarrhal Fever: Understanding Molecular Diagnostics in Context of Epidemiology
por: Li, Hong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ckqo36qhuk46a92dovdaron9c7